Acute Myeloid Testing Market at a CAGR of 13.70% in the forecast period of 2022-2029.
Data Bridge Market Research analyses that the acute myeloid testing market to account USD 1,385.35 million by 2029 and growing at a CAGR of 13.70% in the forecast period of 2022-2029.